Novel contrast-enhanced ultrasound imaging in prostate cancer

World Journal of Urology

Volumn 29, Issue 5, 2011, Pages 581-587

  Smeenge, Martijn ^a   Mischi, Massimo ^b   Laguna Pes, M Pilar ^a   de la Rosette, Jean J M C H ^a   Wijkstra, Hessel ^a,b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b EINDHOVEN UNIVERSITY OF TECHNOLOGY   (Netherlands)

Author keywords

Contrast enhanced ultrasound; Prostate cancer; Quantification; Targeted microbubbles; TRUS

Indexed keywords

CONTRAST MEDIUM;

ARTICLE; ECHOGRAPHY; HUMAN; MALE; METHODOLOGY; PROSTATE TUMOR; RECTUM;

CONTRAST MEDIA; HUMANS; MALE; PROSTATIC NEOPLASMS; RECTUM; ULTRASONOGRAPHY;

EID: 80053645342     PISSN: 07244983     EISSN: 14338726     Source Type: Journal    
DOI: 10.1007/s00345-011-0747-3     Document Type: Article

References (33)

1. Heidenreich A, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V, Mottet N et al (2010) EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol 59: 61-71.
2. Ferlay J, Parkin DM, Steliarova-Foucher E (2010) Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 46: 765-781.
3. Turkbey B, Pinto PA, Mani H, Bernardo M, Pang Y, McKinney YL, Khurana K et al (2010) Prostate cancer: value of multiparametric MR imaging at 3 T for detection-histopathologic correlation. Radiology 255: 89-99.
4. Turkbey B, Albert PS, Kurdziel K, Choyke PL (2009) Imaging localized prostate cancer: current approaches and new developments. AJR Am J Roentgenol 192: 1471-1480.
5. Bueschen AJ, Lockhart ME (2011) Evolution of urological imaging. Int J Urol 18: 102-112.
6. Beemsterboer PM, Kranse R, de Koning HJ, Habbema JD, Schroder FH (1999) Changing role of 3 screening modalities in the European randomized study of screening for prostate cancer (Rotterdam). Int J Cancer 84: 437-441.
7. Engelbrecht MR, Barentsz JO, Jager GJ, van der Graaf M, Heerschap A, Sedelaar JP, Aarnink RGet al (2000) Prostate cancer staging using imaging. BJU Int 86(Suppl 1): 123-134.
8. Beerlage HP, Aarnink RG, Ruijter ET, Witjes JA, Wijkstra H, van De Kaa CA, Debruyne FM et al (2001) Correlation of transrectal ultrasound, computer analysis of transrectal ultrasound and histopathology of radical prostatectomy specimen. Prostate Cancer Prostatic Dis 4: 56-62.
9. Loch T (2007) Computerized transrectal ultrasound (C-TRUS) of the prostate: detection of cancer in patients with multiple negative systematic random biopsies. World J Urol 25: 375-380.
10. Philip J, Hanchanale V, Foster CS, Javle P (2006) Importance of peripheral biopsies in maximising the detection of early prostate cancer in repeat 12-core biopsy protocols. BJU Int 98: 559-562.
11. Braeckman J, Autier P, Soviany C, Nir R, Nir D, Michielsen D, Treurnicht K et al (2008) The accuracy of transrectal ultrasonography supplemented with computer-aided ultrasonography for detecting small prostate cancers. BJU Int 102: 1560-1565.
12. Aigner F, Pallwein L, Junker D, Schafer G, Mikuz G, Pedross F, Mitterberger MJ et al (2010) Value of real-time elastography targeted biopsy for prostate cancer detection in men with prostate specific antigen 1. 25 ng/ml or greater and 4. 00 ng/ml or less. J Urol 184: 913-917.
13. Sedelaar JP, van Leenders GJ, Hulsbergen-van de Kaa CA, van der Poel HG, van der Laak JA, Debruyne FM, Wijkstra H et al (2001) Microvessel density: correlation between contrast ultrasonography and histology of prostate cancer. Eur Urol 40: 285-293.
14. Fregene TA, Khanuja PS, Noto AC, Gehani SK, van Egmont EM, Luz DA, Pienta KJ (1993) Tumor-associated angiogenesis in prostate cancer. Anticancer Res 13: 2377-2381.
15. Sen J, Choudhary L, Marwah S, Godara R, Marwah N, Sen R (2008) Role of colour Doppler imaging in detecting prostate cancer. Asian J Surg 31: 16-19.
16. Takahashi S, Yamada Y, Homma Y, Horie S, Hosaka Y, Kitamura T (2002) Power Doppler ultrasonography-directed prostate biopsy in men with elevated serum PSA levels: an evaluation of the clinical utility and limitations. Urology 60: 248-252.
17. Sakarya ME, Arslan H, Unal O, Atilla MK, Aydin S (1998) The role of power Doppler ultrasonography in the diagnosis of prostate cancer: a preliminary study. Br J Urol 82: 386-388.
18. Kim TK, Lee KH, Khalili K, Jang HJ (2011) Hepatocellular nodules in liver cirrhosis: contrast-enhanced ultrasound. Abdom Imaging. doi: 10. 1007/s00261-011-9686-0.
19. Quaia E (2011) Assessment of tissue perfusion by contrast-enhanced ultrasound. Eur Radiol 21: 604-615.
20. Frauscher F, Klauser A, Volgger H, Halpern EJ, Pallwein L, Steiner H, Schuster A et al (2002) Comparison of contrast enhanced color Doppler targeted biopsy with conventional systematic biopsy: impact on prostate cancer detection. J Urol 167: 1648-1652.
21. Pelzer A, Bektic J, Berger AP, Pallwein L, Halpern EJ, Horninger W, Bartsch G et al (2005) Prostate cancer detection in men with prostate specific antigen 4-10 ng/ml using a combined approach of contrast enhanced color Doppler targeted and systematic biopsy. J Urol 173: 1926-1929.
22. Halpern EJ, Ramey JR, Strup SE, Frauscher F, McCue P, Gomella LG (2005) Detection of prostate carcinoma with contrast-enhanced sonography using intermittent harmonic imaging. Cancer 104: 2373-2383.
23. Sano F, Terao H, Kawahara T, Miyoshi Y, Sasaki T, Noguchi K, Kubota Yet al (2010) Contrast-enhanced ultrasonography of the prostate: various imaging findings that indicate prostate cancer. BJU Int. doi: 10. 1111/j. 1464-410X. 2010. 09735. x.
24. Matsumoto K, Nakagawa K, Hashiguchi A, Kono H, Kikuchi E, Nagata H, Miyajima A et al (2010) Contrast-enhanced ultrasonography of the prostate with Sonazoid. Jpn J Clin Oncol 40: 1099-1104.
25. Goossen TE, De La Rosette JJ, Hulsbergen-van de Kaa CA, van Leenders GJ, Wijkstra H (2003) The value of dynamic contrast enhanced power Doppler ultrasound imaging in the localization of prostate cancer. Eur Urol 43: 124-131.
26. Zhu Y, Chen Y, Jiang J, Wang R, Zhou Y, Zhang H (2010) Contrast-enhanced harmonic ultrasonography for the assessment of prostate cancer aggressiveness: a preliminary study. Korean J Radiol 11: 75-83.
27. Fischer T, Thomas A, Tardy I, Schneider M, Hunigen H, Custodis P, Beyersdorff D et al (2010) Vascular endothelial growth factor receptor 2-specific microbubbles for molecular ultrasound detection of prostate cancer in a rat model. Invest Radiol 45: 675-684.
28. Pochon S, Tardy I, Bussat P, Bettinger T, Brochot J, von Schneider WM, Passantino L (2010) BR55: a lipopeptide-based VEGFR2-targeted ultrasound contrast agent for molecular imaging of angiogenesis. Invest Radiol 45: 89-95.
29. Tardy I, Pochon S, Theraulaz M, Emmel P, Passantino L, Tranquart F, Schneider M (2010) Ultrasound molecular imaging of VEGFR2 in a rat prostate tumor model using BR55. Invest Radiol 45: 573-578.
30. Xuan JW, Bygrave M, Valiyeva F, Moussa M, Izawa JI, Bauman GS, Klibanov A et al (2009) Molecular targeted enhanced ultrasound imaging of flk1 reveals diagnosis and prognosis potential in a genetically engineered mouse prostate cancer model. Mol Imaging 8: 209-220.
31. Schneider M (2008) Molecular imaging and ultrasound-assisted drug delivery. J Endourol 22: 795-802.
32. Yoon CS, Park JH (2010) Ultrasound-mediated gene delivery. Expert Opin Drug Deliv 7: 321-330.
33. Wondergem N, De La Rosette JJ (2007) HIFU and cryoablation-non or minimal touch techniques for the treatment of prostate cancer. Is there a role for contrast enhanced ultrasound? Minim Invasive Ther Allied Technol 16: 22-30.